Editorial: Anti-viral therapy for prevention of perinatal HBV transmission - Extending therapy beyond birth and the risk of post-partum flare

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 1, 2014, Pages 115-116

  Coffin, C S ^a   Lee, S S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; DISEASE EXACERBATION; HEPATITIS B; HUMAN; INFECTION PREVENTION; NOTE; PERINATAL PERIOD; PRIORITY JOURNAL; PUERPERIUM; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY;

EID: 84902113462     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12793     Document Type: Note

References (5)

1. Nguyen V, Tan PK, Greenup A-J, et al,. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment Pharmacol Ther 2014; 39: 1225-34.
2. Wiseman E, Fraser MA, Holden S, et al,. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-92.
3. Pan CQ, Duan ZP, Bhamidimarri KR, et al,. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012; 10: 452-9.
4. Zou H, Chen Y, Duan Z, Zhang H, Pan C,. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012; 19: e18-25.
5. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP,. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 1418-23.